Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    US FDA’s Strategic Priorities based on Groundbreaking Legislations: 2016 and Beyond

    View: 118

    Website https://www.compliance2go.com | Want to Edit it Edit Freely

    Category Houston

    Deadline: February 11, 2016 | Date: February 11, 2016

    Venue/Country: Houston, U.S.A

    Updated: 2016-01-26 17:44:29 (GMT+9)

    Call For Papers - CFP

    Industry: Biotechnology , Medical Device , Pharmaceutical

    Thursday February-11-2016 01:00 PM | 02:00 PM - EST

    DESCRIPTION

    This presentation is intended to discuss US FDA’s Strategic Priorities based on groundbreaking legislations ? 2016 and Beyond.

    Since 2009, there have been a lot of changes being implemented at the FDA. Understanding FDA’s strategic priorities for 2016 and beyond can help firms better understand and use the services or regulatory processes what the FDA offers.

    It is believed that once the firms are familiar with FDA’s regulatory environment and strategic priorities, the firms can prioritize business goals and objectives in view of evolving regulatory science, regulatory plan/strategy including regulatory requirements for product approvals or clearances.

    Based on new laws, statutes and new regulations, the FDA’s strategic priorities have evolved in implementing the statutory and regulatory requirements. It is imperative that the healthcare industry should understand FDA’s strategic priorities for the year 2016 and beyond so that industry can use the relevant and applicable information to better prioritize business processes in strategic response to the evolving regulatory environments.

    This presentation will provide great opportunities to improve industry’s awareness for FDA’s strategic priorities while implementing statutory requirements as set out under the recent groundbreaking legislations for 2016 and beyond.

    In this presentation, the speaker will share FDA’s various programs and strategic priorities for 2016 and beyond.

    Areas To Be Covered in this Webinar:

    Groundbreaking Legislations

    FDA Regulations Implementing Groundbreaking Legislations

    Common Misconception about Laws, Regulations, and New FDA Guidance Documents

    FDA Programs for Food, Drugs, Biologics and Medical Devices

    FDA Accomplishments

    Significant Items from US Senate to the FDA

    FDA User Fees

    FDA Priority Areas

    Regulatory Science Priorities for Devices

    FDA Implementation of Compounding Quality Act Requirements, UDI System and GUDID

    FDA Information Technology: Processes and Developments

    FDA Goals and Objectives for 2016 and Beyond

    Who will benefit:

    Professionals in healthcare industry: drugs, biologics, medical devices/IVDs, combination products, etc.

    Compliance Officers

    Regulatory Affairs

    Clinical Affairs

    Quality Assurance

    Laboratory Personnel

    IT Professionals

    R&D

    Consultants

    Contractors/Subcontractors

    Other professionals interested in this topic

    Webinar Includes:

    Q/A Session with the Expert to ask your question

    Copy of PowerPoint slides (PDF print only)

    60 Minutes Live Presentation

    Certificate of Attendance


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.